MEDP
Medpace Holdings, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$591.92
−0.25%Margins
Gross margin
28.8%
EBITDA margin
21.6%
EBIT margin
21.0%
Net margin
17.7%
FCF margin
26.4%
113.3%
Return on equity
23.9%
Return on assets
105.3%
Return on invested capital
1.33x
Asset turnover
$752.7M
Cash from operations
$18
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026